Alpha memo: resveratrol exercise training translation boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Replace or annotate the ~45% cardiovascular improvement figure: either confirm against the full abstract or restate as 'reported in the abstract' until the full number can be verified.
2. Add publication year for Receipt 1 (2023) alongside the existing Receipt 2 year (2013) so readers can immediately see the cross-decade span of the bundle.
3. Tighten the moderator hypothesis: make explicit that the two receipts do not isolate tissue specificity from species, dose-scaling, duration, or age, so the 'context-dependent split' is a heuristic label, not a tested mechanism.

Major issues

• The Receipt 2 snippet is truncated mid-sentence at 'Exercise training led to a 45', so the ~45% magnitude cannot be cross-checked; manuscript should not present this as a verified number without qualifying that the abstract excerpt is incomplete.

Minor issues

• Receipt 1 is from 2023 (DOI 10.55730/1300-0144.5604) but no year is reported in the prose; adding the year would aid reader calibration.
• The 'why surprising' framing is strong but could more explicitly note that the two receipts differ in endpoint class (mechanistic tissue damage vs. systemic cardiovascular function), not just species and dose.
• Caveats section correctly identifies multiple confounders; consider ranking them so the most decisive ones (species + tissue/endpoint divergence) lead.

Reviewer note

This is a clean two-receipt alpha memo that does what it sets out to do: it draws one bounded, source-grounded research signal (context-dependent resveratrol × exercise interaction) from a murine intestinal protection study and a small human cardiovascular blunting RCT. The title/anchor (resveratrol + exercise translation boundary) aligns with both receipts. Sources are directly on-point, recent enough for a reference bundle, and accurately grounded. The caveats section is specific and material — it names the confounders (species, dose scaling, duration, tissue/endpoint, age) and proposes a falsifier (larger RCT at equivalent dose/load). The main issue is the ~45% figure: the Receipt 2 excerpt is truncated mid-sentence, so that exact number is not verifiable from the bundle as provided, and the manuscript presents it with apparent confidence. This is a bounded fix. The memo also self-hedges appropriately (\'may blunt\', \'tentative moderator hypothesis\'), so claim-evidence alignment is solid modulo the unverifiable statistic. Revise rather than reject: the signal is real, the receipts support it, and the required edits are narrow.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis